Genetic variants contribute to the pathophysiology of eating disorders such as anorexia nervosa (AN) or bulimia nervosa (BN). However, the complex interplay between genetic and environmental factors in eating disorders is only incompletely understood.
The regulation of gene expression is tightly controlled and well balanced in the organism by different mechanisms such as DNA methylation and histone modifications, which are known to be disturbed under several disease conditions. 1 Recent years have witnessed growing interest in epigenetic contributions to psychiatric disorders 2 and evidence for epigenetic alterations has been found in different psychiatric conditions, among them schizophrenia, 2 impaired stress-response 3 and depression. 4 Recently, we have reported genomic and gene-specific DNA hypermethylation in patients with alcohol dependence that was associated with hyperhomocysteinemia. 5 Hyperhomocysteinemia is known to be present also in patients suffering from AN. 6 The aim of this study was therefore to investigate possible alterations of genomic and gene-specific DNA methylation in the peripheral blood of a well-defined sample of females with eating disorders (HEaD-study). 6 This being a pilot-study, we examined the promoter methylation of two genes previously described to be regulated by DNA methylation, the alpha synuclein gene (SNCA) and the homocysteine-induced endoplasmatic reticulum protein (HERP) gene. ). All patients met Diagnostic and Statistical Manual of Mental Disorder (DSM) IV criteria for AN or BN. Diagnoses were established using the German version of the Structured Clinical Interview for DSM IV diagnoses. Written informed consent was obtained from all patients after the procedures had been fully explained to them. Fasting blood samples were collected on admission in ethylenediaminetetraacetic acidcontaining tubes. Homocysteine was determined by high-performance liquid chromatography using a Bio-Rad kit (BioRad, Hercules, CA, USA). Analysis of global and gene-specific DNA methylation and expression of the two genes investigated was performed as was recently described by us. 5, 7 Betweengroup comparisons were performed by t-tests or one-way analysis of variance (ANOVA), followed by all pairwise comparisons according to Bonferroni using SPSS for Windows 14.0 (SPSS Inc., Chicago, IL, USA).
We found a global DNA hypomethylation in patients with AN (47.7719.6%; ANOVA: F = 6.67; P = 0.002) when compared to controls (65.2710.5%; Bonferroni: P = 0.001). In addition, patients with AN showed a trend towards a lower global methylation compared to patients with BN (60.4722.3%; Bonferroni: P = 0.058). There was no difference between patients with BN and controls. After dividing the participants into those with normal homocysteine and those with hyperhomocysteinemia (X11.7 mmol/l), we found a significantly lower DNA methylation in the hyperhomocysteinemia group (50.8721.0% vs 62.2718.8%; t-test: T = À2.25; df = 33.4; P = 0.031). Patients suffering from both, AN and BN had significantly lower levels of SNCA mRNA (AN: DCT À2.2072.2; BN: DCT À3.2473.2; ANOVA: F = 11.7; P < 0.001) than controls (DCT À0.1271.2). Expression of HERP did not differ between groups. We found a significantly higher DNA methylation of the SNCA gene promoter in patients with AN (86.34711.4%; ANOVA: F = 3.38; P = 0.04) compared to controls (74.06723.8%; Bonferroni: P = 0.048). Patients with BN (82.83710.0%) did not differ from patients with AN and controls. No significant differences were found in the amount of DNA methylation in the HERP promoter.
To our knowledge, this is the first study reporting alterations of global and gene-specific DNA methylation in a sample of patients with eating disorders. We found a global DNA hypomethylation in females with AN, but not in those with BN. Elevated plasma homocysteine was associated with a reduced DNA methylation in peripheral blood cells, which is in line with several investigations in healthy probands. 8 
DNA methylation occurs by transfer of a methyl
Letters to the Editor group to cytosine residues in the dinucleotide sequence CpG. 1 A lack of alimentary methyl-group donors, like folate, owing to starvation, may be the underlying cause of both elevated homocysteine and DNA hypomethylation in AN.
To further investigate possible epigenetic contributions to the pathophysiology of eating disorders, we analyzed the expression and promoter-specific DNA methylation of two genes, SNCA and HERP, recently described to be altered in alcohol dependence. 5, 7 We found a decreased SNCA expression in patients with AN, which was associated with a DNA hypermethylation of the SNCA promoter. Although showing a decreased expression of SNCA, we failed to find hypermethylation in the BN groups possibly owing to a lack of power of the study, as there was a trend towards hypermethylation when compared to controls (t-test; P = 0.083), but this was lost after correction for multiple comparisons. The observation that unchanged promotermethylation of the HERP gene was associated with a gene expression comparable to that in the control group may suggest that normal patterns of DNA methylation can be kept constant in the promoter regions of certain genes despite a potential lack of methyl groups.
In conclusion, we found alterations of epigenetic DNA methylation in females with AN. These findings need to be replicated in a larger sample and different genes should be analyzed, and different methods of analyzing methylation patterns of the DNA should be applied. The restriction enzyme-based approach that we have chosen has some disadvantages when compared to bisulfite sequencing methods, mainly the limitation of analysis to one CpG element in the promoter and the need for reliable digestion results. Longitudinal observations, comparing acute illness with the situation after refeeding and recovery, are warranted. Profound knowledge of the epigenetics of eating disorders may help in understanding the geneenvironment nexus postulated for the disorder.
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Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder There is strong evidence demonstrating that genetic inheritance is associated with higher susceptibility to bipolar disorder (BD), but the interaction between gene polymorphisms and biochemical changes remains largely unknown. A common polymorphism in the brain-derived neurotrophic factor (BDNF) gene, which substitutes a valine for a methionine at the codon 66 (val66met) has been implicated to play a role in BD.
1 Specifically, the BDNF val66met polymorphism is associated with susceptibility to rapid cycling 2 and altered cognitive performance in BD subjects. 3 Our group has recently reported that serum BDNF levels are decreased during acute manic and depressive episodes in BD patients, suggesting that the regulation of BDNF might be implicated in mood stabilization. 4 Considering that the val66met polymorphism affects intracellular packaging and activitydependent secretion of BDNF, 5 and that there is a strong positive correlation between brain and serum BDNF levels, 6 we have investigated whether the val66met polymorphism is associated with changes in serum BDNF levels in BD patients and normal controls. We hypothesized a priori that met carriers (met/met þ val/met genotypes) would present lower levels of serum BDNF than the val/val group.
One hundred and seven Caucasian type-I bipolar patients were recruited from the Bipolar Disorders Program (Hospital de Clinicas de Porto Alegre, Brazil). Psychiatric diagnoses were carried out using the Structured Clinical Interview for DSM-IV-Axis I, and manic and depressive symptoms were assessed using the Young Mania Rating Scale (YMRS) and the Hamilton Depression Rating Scale (HDRS), respectively. One hundred and thirty-seven healthy controls were matched by age, gender and education. Control subjects were non-smokers, were not on medication and had no history of major psychiatric disorders, dementia, mental retardation, cancer or tumor and no such disorders in their first-degree relatives. Ten milliliters of blood were withdrawn from each subject
